Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Northstar Gold Signs MOU with Hunan Nonferrous Ltd. to Develop Gold Resource (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Surmodics Inc SRDX

Healthcare Medical Devices
Surmodics, Inc. is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The Company's segments include Medical Device and IVD. The Medical Device segment manufactures and licenses performance coatings, including surface modification coating technologies to improve... see more

Recent & Breaking News (NDAQ:SRDX)

Surmodics to Report Second Quarter of Fiscal 2024 Financial Results on May 1

Business Wire April 19, 2024

Surmodics to Participate in Upcoming Investor Conferences in March and April

Business Wire February 27, 2024

Surmodics Reports First Quarter of Fiscal Year 2024 Financial Results; Updates Fiscal Year 2024 Financial Guidance

Business Wire February 1, 2024

Surmodics Announces Successful Early Clinical Use of Pounce(TM) LP (Low Profile) Thrombectomy System, Designed to Address a Critical, Unmet Need by Facilitating Removal of Thrombi and Emboli Below the Knee

Business Wire January 22, 2024

Surmodics to Host Virtual Annual Meeting of Shareholders

Business Wire January 16, 2024

Surmodics to Report First Quarter of Fiscal 2024 Financial Results on February 1

Business Wire January 16, 2024

Surmodics Announces 24-Month Data from the SWING Trial Presented at VEITHsymposium

Business Wire November 16, 2023

Surmodics Announces TRANSCEND Trial 36-Month Data Presented at 50th Annual VEITH Symposium

Business Wire November 16, 2023

Surmodics to Participate in the Piper Sandler Healthcare Conference on November 28

Business Wire November 14, 2023

Surmodics Reports Fourth Quarter and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 Financial Guidance

Business Wire November 8, 2023

Surmodics Announces TRANSCEND Trial 36-Month Data to be Presented at 50th Annual VEITH Symposium

Business Wire November 7, 2023

Surmodics Announces SWING Trial 24-Month Data to be Presented at VEITH Symposium on November 15

Business Wire November 7, 2023

Surmodics Announces Launch of Preside(TM) Medical Device Coating Technology, Providing Industry-Leading Lubricity and Durability to a Broader Range of Complex Device Applications

Business Wire October 31, 2023

Surmodics to Report Fourth Quarter and Fiscal 2023 Financial Results on November 8

Business Wire October 10, 2023

Surmodics to Participate in Upcoming Investor Conferences in August

Business Wire August 9, 2023

Surmodics Reports Third Quarter of Fiscal Year 2023 Financial Results; Updates Fiscal Year 2023 Financial Guidance

Business Wire August 2, 2023

Surmodics to Report Third Quarter of Fiscal 2023 Financial Results on August 2

Business Wire July 12, 2023

Surmodics Receives FDA Approval for the SurVeil(TM) Drug-Coated Balloon

Business Wire June 20, 2023

Surmodics Receives FDA 510(k) Clearance for Pounce(TM) LP Thrombectomy System

Business Wire June 14, 2023

Surmodics to Participate in the Jefferies Healthcare Conference on June 8

Business Wire May 25, 2023